Exchange: NASDAQ Sector: Basic Materials Industry: Specialty Chemicals
0.00% $0.0500
America/New_York / 4 apr 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 18.47 mill |
EPS: | -1.160 |
P/E: | -0.0400 |
Earnings Date: | Nov 06, 2023 |
SharesOutstanding: | 369.39 mill |
Avg Daily Volume: | 0 mill |
RATING 2023-09-13 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Strong Buy | |
Return On Asset: | Strong Sell | |
DE: | Strong Sell | |
P/E: | Neutral | |
Price To Book: | Strong Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
4/21 | 1/22 | 2/22 | 3/22 | 4/22 | 1/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -0.0400 | sector: PE -48.27 |
PE RATIO: COMPANY / INDUSTRY |
---|
0.00x |
Company: PE -0.0400 | industry: PE 20.25 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ -0.0358 - 0.124 ( +/- 181.00%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-08-29 | White J. Scott | Buy | 0 | |
2023-08-09 | Gund Philip J. | Buy | 0 | |
2023-08-09 | Reiss M. Freddie | Buy | 0 | |
2023-06-05 | Doerr L John | Sell | 0 | 2019 LSA |
2023-06-05 | Doerr L John | Buy | 0 | 2019 LSA |
INSIDER POWER |
---|
76.28 |
Last 91 transactions |
Buy: 37 820 332 | Sell: 7 047 762 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $0.0500 (0.00% ) |
Volume | 46.75 mill |
Avg. Vol. | 0 mill |
% of Avg. Vol | 0 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.